01 Cluj Napocaexpand_more
The clinical trial landscape in Cluj Napoca is strongly centered on oncology and blood cancers, with studies spanning solid tumors and hematologic malignancies. Major efforts focus on improving treatment effectiveness and long-term outcomes for patients with lung cancer, breast cancer, colorectal cancer, lymphoma, and leukemia.
Advanced and early-stage non-small cell lung cancer, including biomarker-driven subtypes
Breast cancer, prostate cancer, and bladder cancer studies
Lymphoma, multiple myeloma, and leukemia research
Trials testing new combinations, targeted therapies, and better post-surgery treatment approaches
Many of these studies are designed to refine cancer care by comparing newer therapies with standard treatment and by identifying options for harder-to-treat disease subtypes.
Respiratory and Pulmonary Diseases
There is also a major focus on respiratory medicine, especially chronic and severe lung disease. Research in this area includes trials for COPD, asthma, bronchiectasis, and interstitial lung disease, aiming to improve symptom control and reduce flare-ups.
Chronic obstructive pulmonary disease and chronic bronchitis
Asthma across mild, moderate, and severe forms
Bronchiectasis and interstitial lung disease
Studies evaluating better maintenance therapy and new anti-inflammatory approaches
These trials reflect a strong interest in helping patients breathe more easily and lowering the burden of long-term lung disease.
Cardiovascular and Kidney Research
Clinical trials in cardiology and nephrology are exploring ways to lower the risk of heart, vascular, and kidney complications. In Cluj Napoca, this includes studies in heart failure, atrial fibrillation, hypertension, stroke prevention, and chronic kidney disease.
Heart failure, atrial fibrillation, and atherosclerotic cardiovascular disease
Chronic kidney disease and kidney-related complications
Hypertension and vascular risk reduction
Trials focused on prevention, better control, and fewer cardiovascular events
Several studies are aimed at improving long-term outcomes for patients with overlapping heart and kidney conditions.
Gastroenterology, Liver Disease, and Metabolic Disorders
Research in digestive diseases and metabolic health is broad, covering inflammatory bowel disease, liver disease, and metabolic dysfunction. Ongoing trials address ulcerative colitis, Crohn’s disease, NASH, hepatitis B, and diabetes, with a clear emphasis on better disease control and organ protection.
Ulcerative colitis and Crohn’s disease
Non-alcoholic steatohepatitis and liver fibrosis
Type 2 diabetes, obesity, and related metabolic conditions
Trials testing new options to improve symptoms, inflammation, and long-term disease outcomes
These studies highlight a growing interest in treatments that can ease chronic gastrointestinal symptoms while also addressing broader metabolic risk.
Immunology, Rheumatology, and Autoimmune Disease
A substantial share of research in the city focuses on autoimmune and inflammatory diseases. Trials are studying conditions such as rheumatoid arthritis, systemic lupus erythematosus, psoriasis, systemic sclerosis, and Sjögren’s disease, often with the goal of reducing immune-driven damage and improving daily function.
Rheumatoid arthritis, psoriatic arthritis, and juvenile psoriatic arthritis
Systemic lupus erythematosus, systemic sclerosis, and Sjögren’s disease
Plaque psoriasis, atopic dermatitis, and related skin inflammation
Studies assessing new immune-targeted treatments for disease control and symptom relief
These trials reflect active research into treatments that may better balance immune suppression with safety and long-term benefit.
Neurology and Mental Health
In neurology and psychiatry, trials are examining both chronic neurological disease and mental health conditions. Key areas include multiple sclerosis, epilepsy, migraine, ADHD, major depressive disorder, and schizophrenia.
Multiple sclerosis and progressive forms of neurological disease
Epilepsy and migraine management
ADHD, major depressive disorder, and bipolar disorder
Research aimed at improving symptom control, quality of life, and functional outcomes
In Cluj Napoca, this area combines brain health research with studies of emotional and behavioral well-being.
Skin diseases and allergic disorders are another visible part of the trial portfolio. Research includes atopic dermatitis, alopecia areata, urticaria, bullous pemphigoid, and seasonal allergic rhinitis, with studies designed to ease symptoms and improve skin comfort.
Atopic dermatitis and plaque psoriasis
Alopecia areata and autoimmune skin conditions
Chronic urticaria and allergy-related disorders
Trials testing new approaches for inflammation, itch, and visible skin disease
These studies often aim to offer better control for conditions that can be both physically uncomfortable and emotionally burdensome.
Infectious Diseases and Immunity
The city’s research activity also includes infectious disease and immunology studies. Trials cover COVID-19, hepatitis B, HIV-1 infection, Clostridioides difficile infection, and other immune-related infections, often with the goal of better prevention or treatment support.
Viral infections such as COVID-19, hepatitis B, and HIV
Bacterial and fungal infections, including difficult-to-treat cases
Immune deficiency and infection-related complications
Studies focused on improving infection control and reducing serious complications
These trials show continued attention to both common and complex infectious conditions.
Endocrine, Metabolic, and Weight-Related Conditions
Several trials address endocrine and metabolic disorders, reflecting growing interest in diseases linked to hormones, metabolism, and body weight. Research includes type 2 diabetes, acromegaly, thyroid cancer, obesity, and hypertriglyceridemia.
Type 2 diabetes and glycemic control
Obesity and related metabolic risk
Hormonal disorders such as acromegaly
Studies evaluating better disease control and reduced long-term complications
These projects support a broader effort to improve chronic disease management across metabolism and hormone-related health.
Urology, Nephrology, and Genitourinary Cancers
Research in urinary and reproductive health includes both cancer and non-cancer conditions. Trials focus on prostate cancer, bladder cancer, renal cell carcinoma, benign prostatic hyperplasia, and chronic kidney disease, including studies that may improve treatment precision.
Prostate cancer, including advanced and recurrent disease
Bladder cancer and kidney cancer
Benign prostatic hyperplasia and kidney-related disorders
Trials seeking better cancer control and improved urinary tract health
These studies are important for patients needing more effective and better-tolerated treatment options.
Rare Diseases, Hematologic Disorders, and Other Specialized Research
Cluj Napoca also supports a wide range of specialized studies in rare diseases and complex blood-related conditions. This includes research in hemophilia, myelofibrosis, thrombocytopenia, amyloidosis, and other uncommon disorders that often need targeted approaches.
Hemophilia and thrombocytopenia
Myelofibrosis and related marrow disorders
Amyloidosis and other rare systemic diseases
Studies aimed at finding better symptom control and safer long-term care
These trials are especially valuable where treatment choices are limited and specialized expertise is needed.
Back to Romania
